Cargando…
Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses?
Women who test positive for the human papillomavirus (HPV) but have normal cytology constitute the predominant subgroup of patients in the screening population in the post-vaccination era. The distribution of HPV genotypes changed dramatically, which was attributable to an increase in HPV vaccinatio...
Autores principales: | Wu, Ming, Ma, Xiaotong, Li, Huiyang, Li, Bijun, Wang, Chen, Fan, Xiangqin, Fan, Aiping, Xue, Fengxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682294/ https://www.ncbi.nlm.nih.gov/pubmed/36438260 http://dx.doi.org/10.3389/fpubh.2022.950610 |
Ejemplares similares
-
Leveraging 16S rRNA data to uncover vaginal microbial signatures in women with cervical cancer
por: Wu, Ming, et al.
Publicado: (2023) -
Analysis of the related factors of atypical squamous cells of undetermined significance (ASC-US) in cervical cytology of post-menopausal women
por: Li, Bijun, et al.
Publicado: (2023) -
Interactions between microbiota and cervical epithelial, immune, and mucus barrier
por: Dong, Mengting, et al.
Publicado: (2023) -
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
por: Kailash, U, et al.
Publicado: (2006) -
16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2019)